Azithromycin in Hospitalised Patients with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Peter W Horby, Alistair Roddick, Enti Spata, Natalie Staplin, Jonathan R Emberson, Guilherme Pessoa-Amorim, Leon Peto, Mark Campbell, Christopher Brightling, Ben Prudon, David Chadwick, Andrew Ustianowski, Abdul Ashish, Stacy Todd, Bryan Yates, Robert Buttery, Stephen Scott, Diego Maseda, J Kenneth Baillie, Maya H Buch, Lucy C Chappell, Jeremy N Day, Saul N Faust, Thomas Jaki, Katie Jeffery, Edmund Juszczak, Wei Shen Lim, Alan Montgomery, Andrew Mumford, Kathryn Rowan, Guy Thwaites, Marion Mafham, Richard Haynes, Martin J Landray, RECOVERY Collaborative Group
doi: https://doi.org/10.1101/2020.12.10.20245944

Article Information

doi 
https://doi.org/10.1101/2020.12.10.20245944
History 
  • December 14, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Peter W Horby1,#,
  2. Alistair Roddick2,
  3. Enti Spata3,
  4. Natalie Staplin3,
  5. Jonathan R Emberson3,
  6. Guilherme Pessoa-Amorim2,
  7. Leon Peto1,
  8. Mark Campbell2,
  9. Christopher Brightling4,
  10. Ben Prudon5,
  11. David Chadwick6,
  12. Andrew Ustianowski7,
  13. Abdul Ashish8,
  14. Stacy Todd9,
  15. Bryan Yates10,
  16. Robert Buttery11,
  17. Stephen Scott12,
  18. Diego Maseda13,
  19. J Kenneth Baillie14,
  20. Maya H Buch15,
  21. Lucy C Chappell16,
  22. Jeremy N Day17,
  23. Saul N Faust18,
  24. Thomas Jaki19,
  25. Katie Jeffery20,
  26. Edmund Juszczak21,
  27. Wei Shen Lim22,
  28. Alan Montgomery21,
  29. Andrew Mumford23,
  30. Kathryn Rowan24,
  31. Guy Thwaites17,
  32. Marion Mafham2,
  33. Richard Haynes3,
  34. Martin J Landray2,#,
  35. RECOVERY Collaborative Group*
  1. 1Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
  2. 2Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom
  3. 3MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom
  4. 4Institute for Lung Health, Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, United Kingdom
  5. 5Department of Respiratory Medicine, North Tees & Hartlepool NHS Foundation Trust, Stockton-on-Tees, United Kingdom
  6. 6Centre for Clinical Infection, James Cook University Hospital, Middlesbrough, United Kingdom
  7. 7North Manchester General Hospital & University of Manchester, Manchester, United Kingdom
  8. 8Wrightington Wigan and Leigh NHS Foundation Trust, Wigan, United Kingdom
  9. 9Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom
  10. 10Northumbria Healthcare NHS Foundation Trust, North Tyneside, United Kingdom
  11. 11North West Anglia NHS Foundation Trust, Peterborough, United Kingdom
  12. 12The Countess of Chester Hospital NHS Foundation Trust, Chester, United Kingdom
  13. 13Mid Cheshire Hospitals NHS Foundation Trust, Crewe, United Kingdom
  14. 14Roslin Institute, University of Edinburgh, Edinburgh, United Kingdom
  15. 15Centre for Musculoskeletal Research, University of Manchester, Manchester, United Kingdom
  16. 16School of Life Sciences, King’s College London, London, United Kingdom
  17. 17Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam, and Nuffield Department of Medicine, University of Oxford, United Kingdom
  18. 18NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust and University of Southampton, Southampton, United Kingdom
  19. 19Department of Mathematics and Statistics, Lancaster University, Lancaster, United Kingdom; MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom
  20. 20Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
  21. 21School of Medicine, University of Nottingham, Nottingham, United Kingdom
  22. 22Respiratory Medicine Department, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
  23. 23School of Cellular and Molecular Medicine, University of Bristol, Bristol, United kingdom
  24. 24Intensive Care National Audit & Research Centre, London, United Kingdom
  1. ↵#Correspondence to: Professor Peter W Horby and Professor Martin J Landray, RECOVERY Central Coordinating Office, Richard Doll Building, Old Road Campus, Roosevelt Drive, Oxford OX3 7LF, United Kingdom. email: martin.landray{at}ndph.ox.ac.uk
Back to top
Posted December 14, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Azithromycin in Hospitalised Patients with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Peter W Horby, Alistair Roddick, Enti Spata, Natalie Staplin, Jonathan R Emberson, Guilherme Pessoa-Amorim, Leon Peto, Mark Campbell, Christopher Brightling, Ben Prudon, David Chadwick, Andrew Ustianowski, Abdul Ashish, Stacy Todd, Bryan Yates, Robert Buttery, Stephen Scott, Diego Maseda, J Kenneth Baillie, Maya H Buch, Lucy C Chappell, Jeremy N Day, Saul N Faust, Thomas Jaki, Katie Jeffery, Edmund Juszczak, Wei Shen Lim, Alan Montgomery, Andrew Mumford, Kathryn Rowan, Guy Thwaites, Marion Mafham, Richard Haynes, Martin J Landray, RECOVERY Collaborative Group
medRxiv 2020.12.10.20245944; doi: https://doi.org/10.1101/2020.12.10.20245944
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area